back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-12-22 17:38 Tx date 2019-12-13 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+50,000 vol $0.30 each |
920,000 | |
| Filed 2019-12-22 17:36 Tx date 2019-12-13 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+100,000 vol $0.30 each |
2,370,000 | |
| Filed 2019-10-01 14:45 Tx date 2019-09-20 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$45,000
+300,000 vol $0.15 each |
300,000 | |
| Filed 2019-10-01 14:44 Tx date 2014-10-30 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-01 14:44 Tx date 2019-09-20 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$30,000
+200,000 vol $0.15 each |
2,270,000 | |
| Filed 2019-06-21 20:11 Tx date 2019-06-18 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+500,000 vol $0.15 each |
2,070,000 | |
| Filed 2019-04-20 18:35 Tx date 2019-04-16 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+370,000 vol |
870,000 | |
| Filed 2019-04-20 18:33 Tx date 2019-04-16 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$37,000
+370,000 vol $0.10 each |
1,570,000 | |
| Filed 2017-10-02 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+500,000 vol |
500,000 | |
| Filed 2017-10-02 Tx date 2014-10-30 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-02 Tx date 2015-02-18 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+200,000 vol $0.50 each |
200,000 | |
| Filed 2017-10-02 Tx date 2017-09-20 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+1,000,000 vol $0.10 each |
1,200,000 | |
| Filed 2017-10-02 Tx date 2014-10-30 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: BUX INVESTMENT LTD (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-01 Tx date 2014-10-30 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: Biomark Technologies Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-10-01 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+400,000 vol $0.15 each |
||
| Filed 2017-10-01 Tx date 2017-09-15 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
2,300,000 | |
| Filed 2017-10-01 Tx date 2014-10-30 |
$BUX
Biomark Diagnostics Inc. |
Bux, Rashid
4 - Director of Issuer
Holder: Biomark Technologies Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|